Antivirals for Hepatitis C Targeting Phosphoinositide Metabolism

Ahmed Kaseb

Novel Point-of-Care Tool to Predict Response to Sorafenib in Hepateocellular Carcinoma

Liver and intrahepatic bile ducts

Pathology

Jian-Min Yuan

Cancer epidemiology cohorts in Shanghai and Singapore

Liver and intrahepatic bile ducts

Norman Wolmark

NRG Oncology Network Group Operations Center

Liver and intrahepatic bile ducts

Surgery / Surgical oncology Radiation Oncology

William G Nelson

Chronic exposure to aflatoxin and the risk of liver cancer, fatty liver disease, liver fibrosis, and diabetes

Liver and intrahepatic bile ducts

Pathology

Marshall Hicks

Clinical Relevance of FGF19 Signaling in the Resistance to Image-guided Therapy in Hepatocellular Carcinoma

Liver and intrahepatic bile ducts

Pathology

Monica M Bertagnolli

Alliance for Clinical Trials in Oncology Operations Center

Liver and intrahepatic bile ducts

Hematology and hematologic malignancies

Stephen G Emerson

Palliative care and end-of-life issues among cancer patients in Soweto, South Africa

Liver and intrahepatic bile ducts

Robert L Murphy

Active Viral Hepatitis Diagnostics to Support Prevention/Treatment of HCC

Liver and intrahepatic bile ducts

Radiation Oncology

Margaret Juliana Mcelrath

Seattle-Lausanne-Kampala CTU

Liver and intrahepatic bile ducts